Research Paper Volume 15, Issue 21 pp 12104—12119
Collaborating single-cell and bulk RNA sequencing for comprehensive characterization of the intratumor heterogeneity and prognostic model development for bladder cancer
Figure 8. Immunotherapy analysis of BLCA patients. (A–C) The survival analysis and ROC curve analysis in all seven utilized datasets. GSE31684 (A); GSE32894 (B); GSE48074 (C). (D) The survival analysis of the TCGA-BLCA patients of high and low riskscore value, shown in the form of KM curve. (E) The survival analysis of the IMvigor210 cohort of BLCA patients of high and low riskscore value, shown in the form of KM curve. (F) The proportion of responsive and non-responsive patients in different risk groups in TCGA-BLCA patients using the chi-square test. (G) The proportion of responsive and non-responsive patients in different risk groups in IMvigor210 cohort using the chi-square test. (H) The box plot showing risk value of non-responsive and responsive patients in TCGA-BLCA cohort. (I) The box plot showing risk value of non-responsive and responsive patients in IMvigor210 cohort.